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Tuberous sclerosis is a developmental genetic dis-
order caused by mutations in TSC1, which results
in epilepsy, autism, and intellectual disability. The
cause of these neurological deficits remains unre-
solved. Imaging studies suggest that the thalamus
may be affected in tuberous sclerosis patients, but
this has not been experimentally interrogated.We hy-
pothesized that thalamic deletion of Tsc1 at distinct
stages of mouse brain development would produce
differential phenotypes. We show that mosaic Tsc1
deletion within thalamic precursors at embryonic
day (E) 12.5 disrupts thalamic circuitry and alters
neuronal physiology. Tsc1 deletion at this early stage
is unique in causing both seizures and compulsive
grooming in adult mice. In contrast, only a subset
of these phenotypes occurs when thalamic Tsc1 is
deleted at a later embryonic stage. Our findings
demonstrate that abnormalities in a discrete popula-
tion of neurons can cause global brain dysfunction
and that phenotype severity depends on develop-
mental timing and degree of genetic mosaicism.
INTRODUCTION
Tuberous sclerosis (TS) is a complex mosaic genetic disorder
that affects one in 6,000 children and commonly presents in
infancy or early childhood, suggesting an early developmental
basis for the disease. TS is characterized by benign hamartomas
in multiple organs, but neurological involvement is common and
debilitating. Patients may experience seizures (70%–90%), intel-
lectual disability (50%), autism (25%–50%), and sleep distur-
bances (McClintock, 2002). Hamartomas in the brain were
thought to cause neurological symptoms, but the extent of
hamartomas does not necessarily correlate with the severity of
neurological impairment (Wong and Khong, 2006). This suggeststhat subtle aspects of brain development or function are per-
turbed in TS.
Genetically, TS is caused by mutations in either of two tumor
suppressor genes, TSC1 or TSC2, and is inherited in an auto-
somal dominant manner. In addition to the inherited mutation,
a somatic mutation in the remaining functional allele results in
loss of heterozygosity and gives rise to isolated TSC null cells
that proliferate and contribute to the formation of hamartomas
(Au et al., 1999). This ‘‘two-hit’’ mechanism results in a mosaic
population of cells in a patient’s organs: a discrete population
that has undergone a second hit to become null for TSC1 or
TSC2 and surrounding heterozygous cells. However, it is unclear
whether this two-hit mechanism underlies neurocognitive as-
pects of TS (Crino et al., 2010). To experimentally emulate this
mosaic state within the brain and to test whether targeted
disruption of Tsc1 in a focal manner can disrupt global brain
function, we employed an inducible CreER/loxP-based method
of gene inactivation in mice, which produces a spatially
restricted, mosaic population of Tsc1 mutant cells surrounded
by genetically unaffected cells.
The TSC1 and TSC2 proteins form a heterodimer that nega-
tively regulates the mTOR pathway, which in turn modulates a
wide array of cellular processes (Hay and Sonenberg, 2004).
The multifaceted nature of the mTOR pathway raises the possi-
bility that the effects of TSC loss of function vary depending on a
cell’s identity, functional role, or developmental state at the time
of TSC mutation. During brain development, cell fate specifica-
tion, cell growth, differentiation, and axonal connectivity are
tightly regulated to establish proper brain architecture and func-
tion. Thus, spatially and temporally controlling Tsc1 deletion in
targeted cell types and comparing the resulting phenotypes
will be instructive to our understanding of this complex disease.
Because our CreER/loxP experimental system is temporally
inducible, we are able to target Tsc1 inactivation at distinct
stages of brain development.
Numerous studies have evaluated how Tsc1/2 deletion affects
the cerebral cortex. Subcortical regions have not been exten-
sively evaluated thus far, although one such structure that war-
rants investigation based on previous findings is the thalamus.
MRI-imaging studies of TS patients show that changes inNeuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc. 895
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performance (Ridler et al., 2007). Thalamic involvement in TS is
relevant because the thalamus provides specific, information-
carrying afferents to the cerebral cortex and plays a crucial
role in higher-order cognitive processes (Saalmann and Kastner,
2011). The thalamus also projects robustly to the striatum, a
pathway implicated in attentional orientation (Smith et al.,
2004). Notably, dysfunction of the thalamus and striatum are
implicated in obsessive compulsive disorder and autism (Hardan
et al., 2008; Fitzgerald et al., 2011). The relay cells of the thal-
amus receive extensive excitatory feedback from the neocortex
and inhibitory inputs from the thalamic reticular nucleus (TRN).
Due, in part, to this extensive reciprocal connectivity, the thal-
amus plays a key role in oscillatory neocortical dynamics and
in the generation of low-frequency rhythms, which are prominent
in specific forms of epileptic activity (Blumenfeld, 2003).We have
used spatially and temporally controlled Tsc1 gene deletion to
address how altered thalamic development has the potential to
perturb widespread neural function and behavior.
RESULTS
Spatiotemporal Contribution of the Gbx2 Lineage
to Adult Thalamic Neurons
To temporally and spatially control Tsc1 gene deletion, we com-
bined three genetically modified mouse alleles (see Figure S1A
available online): (1) Gbx2CreER, which targets CreER expression
to thalamic cells (Chen et al., 2009); (2) Tsc1fl, which is converted
into a null allele (Tsc1D) by Cre-mediated recombination (Kwiat-
kowski et al., 2002); and (3) either R26LacZ (Soriano, 1999) or
R26tdTomato (Madisen et al., 2010), which produce b-galactosi-
dase (b-gal) or red fluorescent protein (RFP), respectively,
upon Cre-mediated recombination. CreER remains quiescent
until it is transiently activated by tamoxifen. Subsequently, the
Tsc1fl gene is permanently converted to Tsc1D and the condi-
tional reporter genes are permanently activated in the thalamus
(Figures S1B and S1C).Gbx2CreER expression has been reported
in the spinal cord (Luu et al., 2011) but, within the brain, regions
outside of the thalamus had only very sparse recombination with
tamoxifen at E12.5 (Figure S1). We validated the fidelity of
Tsc1fl recombination in the thalamus compared to the neocortex
(Figures S1D and S1E). Operationally, we use Tsc1DE12/DE12 to
indicate mutant animals that received tamoxifen on embryonic
day (E) 12.5 and Tsc1DE18/DE18 to indicate mutants that received
tamoxifen on E18.5. We first performed genetic inducible fate
mapping on Gbx2CreER;R26LacZ animals to characterize the
extent, spatial distribution, andmolecular identity of recombined
cells (Figure 1). We administered tamoxifen to pregnant females
carrying Gbx2CreER;R26LacZ embryos at E12.5 or E18.5 and
determined the long-term lineage contribution to the thalamus.
Postnatal brain sections were analyzed by immunohistochem-
istry (IHC) for b-gal expression from the activated R26LacZ allele.
E12.5 fate-mapped cells (green) were distributed widely
throughout the full medial-lateral extent of the thalamus (Figures
1A–1F). In animals that received tamoxifen at E18.5, the spatial
extent of recombination was reduced (Figures 1G–1L). Regions
that underwent recombination at both E12.5 and E18.5 include
the anteromedial and mediodorsal nuclei. The ventrolateral,896 Neuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc.ventromedial, ventrobasal, laterodorsal, and the lateral genicu-
late nuclei underwent recombination at E12.5 but were not
marked at E18.5. Nuclei that underwent extensive recombination
early (E12.5) and moderate mosaic recombination later (E18.5)
include the posterior nucleus and the medial geniculate nucleus.
We investigated whether recombination occurred in a particular
cell type by IHC for b-gal in combination with parvalbumin
(PV, red, Figures 1A–1C and 1G–1I) or calbindin (Calb, red,
Figures 1D–1F and 1J–1L). Within relay nuclei, b-gal+ cells
contributed to both Calb and Calb+ cells at both E12.5 and
E18.5 (Figures 1D–1F and 1J–1L, arrowheads). Although most
excitatory relay neurons did not express any PV+ within their
soma, there were a few examples of neurons with low PV+ levels
that also expressed b-gal at E12.5 (Figures 1A–1C, arrowheads).
Notably, the highly PV+ inhibitory thalamic reticular nucleus
(TRN) did not undergo recombination at either stage.
mTORPathway Dysregulation Occurs Rapidly after Tsc1
Recombination
We used the inducible nature of our system to control the timing
of Tsc1 gene deletion and determine how rapidly mTOR dysre-
gulation occurs. We administered tamoxifen to E12.5 embryos
with Gbx2CreER and either Tsc1+/+ or Tsc1fl/fl. E12.5 is a stage
when thalamic neurons have differentiated and are beginning
to extend axonal projections toward the cortex (Molna´r et al.,
1998). We compared mTOR activity in the Tsc1+/+ and
Tsc1DE12/DE12 thalamus at E14.5 by IHC for the S6 protein phos-
phorylated at Ser240/244 (pS6), which is a reliable readout of
mTOR pathway activity. We observed basal pS6 expression in
the E14.5 Tsc1+/+ brain (Figure 2A), consistent with the require-
ment for mTOR activity during early development (Hentges
et al., 2001). Nevertheless, in the E14.5 Tsc1DE12/DE12 thalamus,
there was an increase in thalamic pS6 levels over controls (Fig-
ure 2B). In E17.5 Tsc1DE12/DE12 embryos, thalamic levels of
pS6were also dramatically increased compared to controls (Fig-
ures 2C and 2D). These experiments show how rapidly neurons
respond to Tsc1 gene inactivation in vivo during embryogenesis.
mTOR dysregulation persisted in the postnatal Tsc1DE12/DE12
thalamus but was negligible in the Tsc1+/+ and Tsc1+/DE12 con-
trols (Figures 2E–2G). R26LacZ reporter activation (b-gal, green)
validated that all genotypes had a similar extent of CreER-
mediated recombination. Similar results were seen with IHC for
pS6(Ser235/236), another mTOR-dependent S6 phosphoryla-
tion site (data not shown).
E12.5 Tsc1 Deletion Alters Morphology and Circuitry
in Mature Thalamic Neurons
To determine whether mTOR dysregulation affected the
morphology of adult thalamic neurons, we quantified soma size
based on the somatodendritic marker microtubule-associated
protein 2 (MAP2). Sections were also stained for pS6 (red).
CreER-mediated recombination produced mTOR dysregulation
in 70% of thalamic neurons in Tsc1DE12/DE12 mice (621 out of
878 MAP2+ neurons). We took advantage of this mosaicism and
sorted neurons into two populations: dysregulated Tsc1DE12/DE12
neurons (pS6+, filled arrowheads) and unaffected neurons
(pS6, open arrowheads, Figure 3B). The geometric mean soma
area of pS6+ Tsc1DE12/DE12 neurons was 403 mm, which was
Figure 1. Gbx2CreER-Mediated Recombination in Thalamic Neurons
(A–F) Tamoxifen at E12.5. Expression of b-gal (green) in medial (A and D), Intermediate (B and E), and lateral (C and F) sagittal sections of adult thalamus.
Colocalization with parvalbumin (PV, red; A, B, and C) or calbindin (Calb, red; D, E, and F) is indicated by arrowheads.
(G–L) Tamoxifen at E18.5. Recombination in medial (G and J), Intermediate (H and K), and lateral (I and L) sagittal section of adult thalamus showing recombined
cells (b-gal, green) and PV+ (G–I) or Calb+ (J–L) neurons. Scale bar in (A) (270 mm) applies to low-magnification panels; scale bar in (A3) (30 mm) applies to high-
magnification panels. Thalamic nuclei: AM, anteromedial; LD, laterodorsal; LG, lateral geniculate; MD, mediodorsal; MG, medial geniculate; Po, posterior; PP,
peripeduncular; SubG, subgeniculate; TRN, thalamic reticular; VB, ventrobasal; VL, ventrolateral; VM, ventromedial; a.c., anterior commissure; f, fornix; fr,
fasciculus retroflexus; hipp, hippocampus; i.c., internal capsule; IGL, intergeniculate leaflet. See also Figure S1.
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Tsc1 Deletion during Thalamic Developmentsignificantly larger than Tsc1+/+ (220 mm2), Tsc1DE12/+ (209 mm2),
andpS6 Tsc1 DE12/DE12 (203 mm2) neurons (p = 0.003, n = 3mice
per genotype, Figure 3B, see Table S1 for variability esti-
mates). Because normal-sized pS6 cells neighbored enlarged
pS6+ cells, we conclude that neuron overgrowth occurs in a
cell-autonomous manner. We also detected substantial PV
expression in fibers within the internal capsule of Tsc1DE12/DE12
brains (Figures 3E and 3E0), which was absent in controls (Fig-
ures 3C and 3C0). Because corticothalamic and thalamocortical
axons (TCAs) intermingle in the internal capsule, we assayed
for R26tdTomato expression. Comparison of RFP/PV colocaliza-
tion in the fibers (Figures 3C, 3C0 and 3E, 3E0) and cell bodies of
thalamic relay neurons (Figures 3D, 3D0, 3F, and 3F0) confirmed
that the PV+ signal was from the Tsc1DE12/DE12 relay neurons
and their TCAs. Because previous TS mouse models have
described myelination defects and astrocytosis (Meikle et al.,
2008;Wayet al., 2009;Carsonet al., 2012),weassayed formyelin
basic protein (MBP) and glial fibrillary acidic protein (GFAP).
Control mice had clear MBP labeling throughout the brain,including within the thalamus and the internal capsule, and this
did not differ between mutants and controls (Figure S2). Only
sporadic GFAP+ cells were observed in the thalamus of both
mutants and controls (Figure S2). Because the enlarged
Tsc1DE12/DE12 thalamic neurons were reminiscent of dysmorphic
neurons in neuronal storage disorders, we assayed for GM2
ganglioside, which accumulates in these disorders (Zervas
et al., 2001). GM2 was not detected in Tsc1+/+ or Tsc1DE12/DE12
thalamic neurons (data not shown).
We next investigated whether deleting Tsc1 at E12.5 affected
thalamocortical circuit development. We took advantage of the
highly organized and stereotyped projections from the thalamic
ventrobasal nuclear complex (VB) to the vibrissa barrels in layer
IV of primary somatosensory cortex (SI) (Woolsey and Van der
Loos, 1970). We used R26tdTomato to label thalamic projections
for neural circuit analysis. In control animals (adults), TCAs inner-
vated layer IV of somatosensory cortex in discrete clusters cor-
responding to individual vibrissae (Figure 4A, region 1), similar to
descriptions using nongenetic labeling (Wimmer et al., 2010). InNeuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc. 897
Figure 2. Conditional Deletion of Tsc1
in the Thalamus Causes Rapid mTOR
Dysregulation
(A and B) pS6 (red) immunolabeling in E14.5
Tsc1DE12/DE12 embryos.
(C and D) E17.5 Tsc1DE12/DE12 embryos had a
robust increase in pS6 (red) compared to controls.
(E–G) Adult Tsc1DE12/DE12 mutants had high pS6
levels (red). R26LacZ (b-gal, green) independently
showed similar recombination efficiency across
genotypes. Control and mutant sections were
imaged with identical exposure settings. n R 3
animals per genotype per stage. Scale bars
represent 30 mm in (A), (B), and (E)–(G) and 15 mm in
(C) and (D).
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Tsc1 Deletion during Thalamic Developmentcontrast, Tsc1DE12/DE12 mice (adults) had a diffuse pattern of
cortical innervation: individual barrels were indistinguishable in
layer IV (Figure 4B, region 1) and projections were overabundant
in the deep layers (arrow). Within the internal capsule, TCA fasci-
cles appeared less sharply defined compared to controls (Fig-
ures 4A and 4B, region 2). We confirmed these findings by ste-
reotaxic injection of lentiviral-GFP into VB in control and
mutant animals (Cruikshank et al., 2010), which filled infected
neurons with GFP, including their axons and terminal projections
(Figure S3).
To assess the effect of the disorganized TCAs on genetically
normal cortical targets, we used cytochrome oxidase (CO)
staining, which is enriched in the dendritic mitochondria of layer
IV spiny stellate barrel neurons (Wong-Riley and Welt, 1980) and
nicely delineates the barrel hollow structures (Figures 4C–4J). In
controls, RFP+ TCAs were enriched in the CO+ barrel hollows
and largely excluded from the surrounding septa (Figure 4E,
asterisks and arrowheads, respectively). In Tsc1DE12/DE12
mutants, the TCAs were not only localized to barrel hollows (Fig-
ure 4I, asterisks) but were also heavily distributed throughout
the septal regions (arrowheads). The CO staining pattern was
also altered in Tsc1DE12/DE12 brains, suggesting that the cortical
barrels were improperly patterned (Figure 4, compare 4C and
4D to 4G and 4H). The small vibrissa barrels were particularly898 Neuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc.indistinct in the Tsc1DE12/DE12 cortex
(Figures 4D and 4H, gray regions), which
was a phenotype reminiscent of that
described in mGluR5 knockout mice
(She et al., 2009). To quantitatively
assess the large barrels (Figures 4D
and 4H, orange regions), we outlined
the limits of the SI vibrissa region and
the individual barrels based on CO stain-
ing in a genotype-blinded manner. The
average barrel size was larger in mutants
(58 mm2) compared to controls (37 mm2,
p < 0.001, n R 72 barrels across 3 mice
per genotype, two-sample two-tailed t
test; Figure 4K). Quantification of the
septal proportion of the barrel region
based on CO staining showed no signifi-
cant difference between Tsc1DE12/DE12(21%) and controls (25%, p = 0.16, n = 3 mice per genotype,
two-sample two-tailed t test; Figure 4L). To determine whether
the organization of the cortical cell bodies was altered, we com-
bined NeuN antibody labeling with CO staining to quantify cell
density in the barrel hollows (outer limit of the CO+ barrel hollow
is indicated by the dashed lines in Figures 4F and 4J) and the
surrounding barrel wall region (indicated by the solid lines in Fig-
ures 4F and 4J) (Narboux-Neˆme et al., 2012). Mutants had lower
neuron density in the barrel wall region (3.7 neurons/mm2) than
controls (Figure 4M; 4.5 neurons/mm2). This same trend applied
to the barrel hollow region (Tsc1DE12/DE12 3.2 neurons/mm2;
Tsc1+/+ 3.5 neurons/mm2, pwall < 0.001, phollow = 0.020, n R
20 nonadjacent barrels across 3 animals per genotype, two-
sample two-tailed t test; Figure 4M). Together, these experi-
ments confirmed that thalamic Tsc1 inactivation causes
mTOR dysregulation, cell overgrowth, aberrant PV expression,
and altered thalamocortical projections that affect the geneti-
cally normal neocortex.
Later Deletion of Tsc1 Causes More Subtle Cellular
Changes than Those Arising from Early Inactivation
We administered tamoxifen at E18.5 to compare the effects of
thalamic Tsc1 inactivation at a later developmental stage. By
E18.5, thalamic neurons have fully differentiated, their axonal
Figure 3. Cellular Phenotypes Caused by Tsc1 Deletion in Thalamus at E12.5
(A) Thalamocortical regions of interest.
(B) Sections from adult mice were immunolabeled for MAP2 (green), pS6 (red), and counterstained with hoechst (blue). Thalamic neurons of Tsc1+/+ and
Tsc1DE12/+mice were pS6. Recombination produced a mosaic thalamus of unaffected (pS6, open arrowhead) and affected (pS6+, filled arrowhead) neurons.
Soma area is plotted by genotype and pS6 status. Numbers of neurons are listed and geometric means are indicated by horizontal lines.
(C–F0 ) Analysis of PV (green) and RFP (red) revealed PV+ fibers in the internal capsule of Tsc1DE12/DE12mice (E and E0, arrowheads), but not in controls (C and C0).
Soma of Tsc1DE12/DE12 RFP+ neurons were also PV+ (F and F0, arrowheads, which was not seen in controls (D and D0)). n = 3 animals per genotype. Scale bars
represent 32 mm in (B) and 48 mm in (C)–(F). **p < 0.005. See also Figure S2.
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Tsc1 Deletion during Thalamic Developmentprojections have accumulated in the subplate of their cortical
target regions, and they are beginning to invade the cortical
layers (Molna´r et al., 1998). Upon reaching adulthood,
Tsc1DE18/DE18 brains were analyzed for mTOR activity and cell
size (Figure 5A). mTOR was dysregulated in 29% of neurons
(221 out of 542 MAP2+ cells) in the Tsc1DE18/DE18 thalamus,
as evidenced by increased pS6 (Figure 5A). We analyzed
cell size as described in Figure 3. Although some pS6+
Tsc1DE18/DE18 neurons skewed toward larger cell sizes
than pS6 neurons, on average, pS6+ Tsc1DE18/DE18 neurons
(359 mm2) were not significantly larger than pS6 Tsc1DE18/DE18
(246 mm2), Tsc1DE18/+ (242 mm2), or Tsc1+/+ (253 mm2) cells
(p = 0.11; Figure 5A). We observed rare pS6+ neurons in theTsc1+/+ (2 out of 632 cells, average size 304 mm2, data not
shown) and Tsc1DE18/+ (8 out of 1,069 cells, average size:
277 mm2) thalamus, which were not graphed for clarity. Unlike
the E12.5 findings, aberrant PV expression was not apparent
in either axons or cell bodies of Tsc1DE18/DE18 thalamic neurons
(Figures 5B and 5C, region 3, data not shown). Tsc1DE18/DE18
thalamocortical projections appeared coarse within the internal
capsule and overabundant within deep cortical layers (Figures
5B and 5C, arrows), similar to the E12.5 findings. Because of
the different recombination pattern, the vibrissal barrel-projec-
ting neurons in VB did not undergo substantial recombination
and thus were not labeled by the R26tdTomato reporter. For this
reason, TCA innervation of the vibrissa barrels could not beNeuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc. 899
Figure 4. Tsc1DE12/DE12 Mutants Have Abnormal Thalamocortical Circuits
(A and B) RFP+ TCAs (red) delineated individual vibrissa barrels in adult Tsc1+/+ neocortex but were diffuse in Tsc1DE12/DE12 mutants (region 1). Mutants had
excess axonal processes in deep cortical layers (arrow) and RFP+ TCA fascicles that were less defined in the internal capsule (region 2).
(C–J) Cortical vibrissa barrels stained with cytochrome oxidase (CO).
(C and D) Controls had well-defined CO+ barrels (brown) separated by CO negative septa.
(E and I) Tsc1+/+ RFP+ TCAs (red) targeted the CO+ barrel hollows (black, asterisks) but were less restricted in Tsc1DE12/DE12 mice.
(F and J) Barrel neurons (NeuN+, green) clustered around the perimeter of CO+ barrel hollows (black). Dashed line represents extent of CO+ barrel hollow. Solid
line represents 15 mm outer perimeter (‘‘wall’’) used for quantification in (M).
(G and H) Tsc1DE12/DE12 cortex had misshapen barrels (brown) and small vibrissa barrels were nearly indistinguishable (gray).
(K) Average CO+ barrel size was larger in Tsc1DE12/DE12 mutants.
(L) The septa proportion showed no difference.
(M) Tsc1DE12/DE12 mice had lower neuron density in the barrel wall and hollow versus Tsc1+/+ animals. Scale bars represent 240 mm in (A) and (B), 61 mm in (A1),
(A2), (B1), and (B2), and 130 mm in (F) and (J). thal, thalamus; str, striatum; ctx, neocortex. *p < 0.05, **p < 0.005. Data are represented as mean ± SD. See also
Figure S3.
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Figure 5. Tsc1 Deletion at E18.5 in the Thalamus Causes Excessive Thalamic Axons
(A) Control and Tsc1DE18/DE18 sections from adults were immunostained forMAP2 (green) and pS6 (red). Soma sizewas graphed by genotype and pS6 expression
and showed no significant difference. Note that pS6+ neurons were rarely observed in Tsc1+/+ (two cells) and Tsc1DE18/+ brains (eight cells) and were not graphed
for clarity.
(B andC) Tsc1+/+ (B) and Tsc1DE18/DE18 (C) sections were immunolabeled for pS6 (green) and RFP (red). Tsc1DE18/DE18 TCAswere superfluous and disorganized in
deep cortical layers (region 1, arrow) and internal capsule (region 2, arrow). PV (region 3, green, from adjacent sections) was absent from Tsc1DE18/DE18 and
Tsc1+/+ TCAs (red). Scale bars represent 8 mm in (A), 240 mm in (B) and (C), 61 mm in (B1), (B2), (C1), and (C2), and 57 mm in (B3) and (C3). See also Figure S4.
Neuron
Tsc1 Deletion during Thalamic Developmentvisualized by RFP expression. Nevertheless, we assessed
vibrissa barrel formation using CO staining, which showed
that the Tsc1DE18/DE18 somatosensory cortex did not have any
patterning disruptions (Figure S4).
Intrinsic Physiology Is Abnormal in Tsc1DE12/DE12,
but Not Tsc1DE18/DE18- Thalamic Neurons
To interrogate the functional effects of Tsc1 deletion at E12.5
versus E18.5 on individual cells, we performed whole-cell
patch-clamp recordings on thalamic VB neurons in mature
thalamocortical slices (Figure 6). (For all data in this section,
see Table S1 for variability estimates, nonsignificant means,
and p values.) We recorded from VB because it is easily identifi-
able and its relay neurons exhibit stereotyped, well-character-
ized physiological properties (Landisman and Connors, 2007).
We used RFP fluorescence from the R26tdTomato reporter allele
to target our recordings to recombined neurons. Biocytin wasadded to the recording pipette to identify neurons post hoc,
reconstruct their morphology, and confirm mTOR
dysregulation in mutant neurons (Figure 6A). We characterized
the intrinsic membrane properties of Tsc1DE12/DE12 and
Tsc1DE18/DE18 VB neurons compared to neurons from their
respective Tsc1+/+ littermates. Tsc1DE12/DE12 VB neurons had
significantly lower input resistance than neurons in Tsc1+/+ litter-
mates (72.6 MU versus 137.2 MU, p = 0.001; Figure 6B). In addi-
tion, Tsc1DE12/DE12 VB neurons had a higher capacitance than
Tsc1+/+ neurons (417.6 pF versus 219.7 pF, p = 0.004, Figure 6B).
In contrast, Tsc1DE18/DE18 neurons did not differ from their con-
trols in either resistance or capacitance (Figure 6B). The mem-
brane time constant was unchanged in Tsc1DE12/DE12 and
Tsc1DE18/DE18 compared to controls (Figure 6B), because the
decrease in resistance offset the increase in capacitance.
We also analyzed the properties and dynamics of action
potentials in VB neurons (Figure 6C). Action potential thresholdsNeuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc. 901
Figure 6. Tsc1DE12/DE12 Thalamic Neurons Have Altered Electrophysiological Properties
(A) DIC/fluorescence shows electrode (yellow dashed lines) targeted to a RFP+ (red) VB neuron. Neurons were filled with biocytin (green) and immunostained for
pS6 (white, insets). Morphology was reconstructed as shown below each filled neuron.
(legend continued on next page)
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Tsc1 Deletion during Thalamic Developmentin Tsc1DE12/DE12 neurons were similar to those of Tsc1+/+.
However, Tsc1DE12/DE12 neurons, when compared to Tsc1+/+
neurons, had significantly larger spike amplitude (82 mV
versus 70 mV, p = 0.0002) and faster rates of depolarization
(618 mV/ms versus 423 mV/ms, p = 0.0001) and repolarization
(263 mV/ms versus 151 mV/ms, p < 0.0001) (Figure 6C).
Tsc1DE18/DE18 spikes did not differ significantly from those of
Tsc1+/+ neurons in terms of amplitude, depolarization rate, or
repolarization rate (Figure S5). VB action potentials are typically
followed by fast and slow afterhyperpolarizations (AHPs) and
an afterdepolarization (ADP) of intermediate duration (Figure 6D,
black trace). To compare these events, we summed the total
area under the postaction potential trajectory, which revealed
that the Tsc1DE12/DE12 neurons had significantly more negative
afterpotentials compared to controls (177 mV*ms versus
64 mV*ms, p = 0.0026; Figure 6D). The Tsc1DE18/DE18 afterpo-
tentials did not differ significantly from controls (Table S1).
Thalamic relay neurons fire in both tonic and bursting modes,
depending on the state of the resting membrane potential. We
characterized tonic firing by holding the membrane potential
at 50 mV and applying steps of depolarizing current. While
the amplitudes of Tsc1+/+ action potentials declined over the first
100 ms of spiking (adaptation), the amplitudes of Tsc1DE12/DE12
action potentials remained constant (Figure 6E, arrows). The
relationship between firing frequency and stimulus current was
roughly linear for bothTsc1+/+ andTsc1DE12/DE12 cells (Figure 6F).
The average slope of the frequency/current relationship for
Tsc1DE12/DE12 cells (0.27 Hz/pA) was significantly lower than
that of Tsc1+/+ cells from littermate controls (0.53 Hz/pA,
p < 0.001, nR 11 cells recorded from nR 3 animals per group;
Figure 6G). Frequency/current relationships of Tsc1DE18/DE18
cells did not differ from those of littermate controls (Figures 6G
and S5). We next characterized the cells’ burst firing by holding
membrane potentials initially at60 mV, then injecting a 1 s step
of current sufficient to bring the membrane to 70 mV. Upon
release of the current, VB neurons fired a single burst of spikes
(Figure 6H). Each burst comprised a similar number of action
potentials that did not vary by genotype; however, the mean
duration of the Tsc1DE12/DE12 bursts were shorter. Figure 6I plots
the intraburst frequency as a function of spike number within the
bursts; Tsc1DE12/DE12 neurons had a significantly higher mean
spiking frequency throughout the burst (401 Hz) compared to
Tsc1+/+ littermate controls (mean of 339 Hz, p = 0.026).
Tsc1DE18/DE18 neurons were not significantly different from neu-(B) Tsc1DE12/DE12 neurons (red) had lower membrane input resistance and high
controls (black). Note that Tsc1DE18/DE18 mutants (pink) and their controls (gray)
(C) Representative traces from control and Tsc1DE12/DE12 neurons (left) show tha
potential dynamics (right) were significantly different with respect to depolarizati
(D) Tsc1DE12/DE12 spike afterpotentials (red) were more negative during the fast
postspike membrane potential was integrated over time and quantified by integr
(E) Representative tonic voltage response of a Tsc1+/+ and Tsc1DE12/DE12 neuron
(F) Peak firing frequency per current step (F/I) is plotted for Tsc1+/+ (black, n = 12
(G) Linear slopes of the F/I curves are quantified.
(H) Representative voltage response of a Tsc1+/+ and a Tsc1DE12/DE12 thalamic n
(I) Intraburst firing frequency as a function of spike number within each burst is p
(J) Mean intraburst firing frequencies are quantified. Note that Tsc1DE18/DE18mutan
plots represent minimum, first quartile (Q1), median, Q3, and maximum. Outliers (
20 mm (DIC) and 30 mm (biocytin/morphology). *p < 0.05, **p < 0.005. See also Frons of Tsc1+/+ littermates (Figures 6J and S5). These experi-
ments revealed that the enlarged Tsc1DE12/DE12 neurons require
stronger input currents to modify their membrane potentials,
have larger, faster action potentials, and have altered firing prop-
erties in both tonic and bursting mode, compared to wild-type
VB neurons, whereas Tsc1DE18/DE18 neurons were unaltered.
Thalamic Tsc1 Deletion at E12.5 and E18.5 Causes
Abnormal Neural Activity and Behavior
To determine whether the changes in thalamic development and
physiology impact neocortical physiology, we recorded local
field potentials (LFPs) in the vibrissal representation of primary
SI of adult anesthetized mice. We chose SI because it receives
robust input from VB, where we detected changes in circuit
organization and whole-cell physiology. We confirmed targeting
to barrel cortex by stimulating vibrissae to drive sensory-evoked
responses (data not shown). We observed prominent low-fre-
quency oscillations in both Tsc1DE12/DE12 and Tsc1DE18/DE18
mice (Figures 7A–7C, n = 6 Tsc1+/+, n = 3 Tsc1DE12/DE12, n = 5
Tsc1DE18/DE18 mice). Quantitative analysis of LFP activity
showed that mutants had higher power across multiple fre-
quencies, particularly in the 3 Hz range (Figure 7D). This is a
frequency associated with spike-and-wave epileptiform activity,
which is related to altered thalamic dynamics (Blumenfeld,
2003). Mutants had significantly higher 3 Hz power than controls
(p = 0.008, Figure 7E), which was evident in the comparison
across all individuals (controls in black/gray, mutants in red/pink
triangles). Further, the number of epochs of high-power 3 Hz
activity lasting R20 s was significantly higher in Tsc1DE12/DE12
(red triangles) and Tsc1DE18/DE18 (pink triangles) mutant animals
compared to controls (p = 0.028, Figure 7F). Older (>8 months)
Tsc1DE18/DE18 animals and controls were also assessed to
account for possible age-related differences in brain activity.
These data points are differentiated by black outlines in Figures
7E and 7F.
We addressed whether there were any behavioral ramifi-
cations of this altered brain activity. At 2 months of age,
Tsc1DE12/DE12 mice seemed to groom more frequently than con-
trol littermates and developed severe skin lesions (Figure 7G,
inset). Because control littermates never developed lesions but
were housed in the same cage as affected mice, we hypothe-
sized that the lesions were due to the excessive self-grooming,
rather than environmental factors, fighting, or allogrooming.
Importantly, overgrooming was apparent before woundser input capacitance but unchanged time constants compared to littermate
are also plotted.
t Tsc1DE12/DE12 action potentials were faster and larger. Tsc1DE12/DE12 action
on rate, maximum amplitude, and repolarization rate.
(fAHP) and during the slow phase (sAHP) compared to controls (black). Total
ating the voltage signal over 280 ms (right).
to current injections (400 pA, top and 200 pA, bottom).
) and Tsc1DE12/DE12 (red, n = 17) neurons.
euron to hyperpolarizing current step. Insets show rebound bursts.
lotted for Tsc1+/+ (black, n = 11) and Tsc1DE12/DE12 (red, n = 18) neurons.
ts (pink) did not significantly differ from their controls (gray; B, D, G, and J). Box
open circles) were >Q3 + 1.5*IQR or <Q1 1.5*IQR. Scale bars in (A) represent
igure S5 and Table S1.
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Figure 7. Abnormal Brain Activity and Be-
haviors Caused by Thalamic Tsc1 Deletion
(A–C) LFPs in primary somatosensory neocortex
were altered in adult Tsc1DE12/DE12 and
Tsc1DE18/DE18 mutants.
(D) Average power spectra of mutants and con-
trols (tamoxifen at E12.5 and E18.5 experiments
were pooled together) shows increased power
between 2–4 Hz. Lines and shading represent
mean ± SEM.
(E) Three hertz was normalized to 1 Hz power for
controls (black, E12.5; gray, E18.5) and mutants
(red, Tsc1DE12/DE12; pink, Tsc1DE18/DE18). Data
points with black outlines represent recordings
performed on aged animals (>8 months).
(F) Greater than or equal to twenty second epochs
of high-power 3 Hz activity are plotted.
(G) The percentage of time spent grooming is
plotted by genotype. Tamoxifen at E12.5 and
E18.5 graphs share a y axis. Inset: a Tsc1DE12/DE12
mouse that developed a wound from over-
grooming.
(H) Number of seizures per hour of observation
time is plotted by genotype. Tamoxifen at E12.5
and E18.5 graphs share a y axis. Inset: contorted
posture typically observed during seizures.
*p < 0.05, **p < 0.005. See also Figure S6.
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grooming but rather a result of it. To confirm this, animals were
videotaped for 8 min periods twice a week in their homecage
before wounds appeared. An observer scored the amount
of time spent grooming by each mouse in a genotype-
blinded manner. Tsc1DE12/DE12 mice spent significantly more
of their time grooming (24.1%, 95% confidence interval (CI95):
21.8%–26.5%) than Tsc1+/+ (3.0%, CI95: 2.4%–3.9%) and
Tsc1DE12/+ (3.8%, CI95: 3.0%–4.9%) mice (p < 0.0001, n R 11
mice per genotype; Figure 7G). In contrast, Tsc1DE18/DE18 mice
displayed no overt phenotypes by 3 months of age (n = 17)904 Neuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc.and did not develop wounds or groom
more often than Tsc1+/+ or Tsc1DE18/+ lit-
termates, regardless of age (n = 25 and
n = 6 respectively, Figure 7G).
Tsc1DE12/DE12 mice also exhibited
spontaneous seizures beginning around
2 months of age, consistent with the in-
crease in 3 Hz LFP activity. The seizure
events were highly stereotyped and
began with prolonged grooming of the
hindlimb, followed by loss of upright
posture, then a tonic-clonic state during
which the body entered into a convulsive,
twisted posture typically lasting 10 s (Fig-
ure 7H, inset; Movie S1). An observer
blinded to genotype quantified the fre-
quency and duration of seizures. The
Tsc1DE12/DE12 mice averaged 3.7 sei-
zures/hr (CI95: 2.0–6.9 seizures/hr), while
control littermates never exhibited sei-
zures (Figure 7H). Ninety-one percent ofthe Tsc1DE12/DE12 mice (10/11) that were analyzed experienced
convulsive seizures as described above during the observation
periods. While the remaining mouse did not have overt seizures,
it did display abnormal behavior in that it remained in a motion-
less, sleep-like state for minutes at a time, which may have
been absence seizures. In contrast, Tsc1DE18/DE18 mice did not
exhibit seizures at 2 months of age. However, by 8 months of
age, four of the 17 Tsc1DE18/DE18mice had experienced a seizure
(Figure 7H, Movie S2), but these rare seizure events only
occurred upon handling. Thus, we conclude that 100% of
Tsc1DE12/DE12 mice and 24% of Tsc1DE18/DE18 mice displayed
Neuron
Tsc1 Deletion during Thalamic Developmentabnormal behavior, with some variation in form and severity.
Notably, the severity of the grooming and the seizure pheno-
types was not correlated within individuals.
BecauseGbx2CreERmediates recombination in the spinal cord
at E12.5 (Luu et al., 2011), we tested peripheral sensory and mo-
tor function (Figure S6). We did not detect a significant difference
in tactile sensitivity (von Frey filament test, p = 0.315) or motor
function (wire hang assay, p = 0.134) between control and
Tsc1DE12/DE12 animals. We also showed that thermal pain sensi-
tivity was unaffected in Tsc1DE12/DE12 mutants (hot plate test,
p = 0.188). BecauseGbx2CreER is no longer expressed in the spi-
nal cord after E14.5 (John et al., 2005), we did not perform similar
tests on Tsc1DE18/DE18 animals. Taken together, our collective
analysis of thalamocortical circuitry, neuronal physiology, and
neocortical local field potentials strongly suggest that the pri-
mary drive of these Tsc1DE12/DE12 or Tsc1DE18/DE18 phenotypes
is mTOR dysregulation in the thalamus.
DISCUSSION
TS is a developmental mosaic genetic disorder caused by dis-
rupting the TSC/mTOR pathway. In this study, we tested the
hypothesis that disrupting the mTOR pathway elicits different
phenotypes depending on the identity and developmental state
of cells in which Tsc1 is deleted and mTOR is dysregulated.
Genetic circuit tracing showed that Tsc1DE12/DE12 thalamic
projections are disorganized and have excessive processes
that innervate layer IV septal regions of the somatosensory barrel
cortex. This phenotype may result from the lack of activity-
dependent pruning or excess axonal ramifications filling intra-
barrel spaces. Our observations are consistent with previous
reports describing abnormal axonal targeting of retinal projec-
tions in both the Drosophila and mouse brain, in which Tsc1
mutant axons overshoot their target and have branches that
terminate outside the normal target regions (Knox et al., 2007;
Nie et al., 2010). It is probable that other cortical areas receive
similarly disorganized Tsc1DE12/DE12 thalamic inputs. We also
analyzed Tsc1DE18/DE18 TCA projections as they traversed the
striatum and entered the cortex. Similar to Tsc1DE12/DE12, there
was a qualitative excess of RFP+ Tsc1DE18/DE18 TCA projections
within the deep cortical layers. However, a direct comparison of
Tsc1DE18/DE18 and Tsc1DE12/DE12 vibrissa barrel innervation was
precluded because of their different recombination patterns.
Regardless, these thalamocortical projection phenotypes in
deep layers are consistent with disrupted neuronal processes
in response to mTOR dysregulation (Choi et al., 2008).
We uncovered multiple electrophysiological alterations upon
early deletion of Tsc1. The increased input capacitance and
reduced input resistance are both consistent with increased
membrane as a result of cell growth. Notably, action potential dy-
namics were also altered, yet spike threshold potentials were un-
affected. The altered action potentials of Tsc1DE12/DE12 neurons
may partially compensate for the changes in passive properties.
As the input resistance of a neuron falls, larger synaptic currents
are required to modify membrane voltage. Mutant Tsc1DE12/DE12
neurons also have larger amplitude, briefer action potentials
with normal thresholds, and rates of rise and fall that are consider-
ably faster thannormal. Themaximumrate-of-riseof anactionpo-tential is proportional to peak inward sodium current inmany neu-
rons (Cohen et al., 1981). Therefore, these changes in spike
kinetics strongly suggest that voltage-gated sodium and potas-
sium channels are altered in the mutant cells. The spike shapes
are consistent with either higher membrane channel densities or
altered single-channel properties, such as subunit composition
orphosphorylation, that affect conductanceandgatingdynamics.
In support of these possibilities, the mTOR pathway has been re-
ported to control expression levels and subunit composition of
some voltage-gated ion channels (Raab-Graham et al., 2006).
Multiple ion channel involvement is further suggested by changes
in both the tonic and burst firing modes of mutant cells. The
reduced slope of the tonic frequency/current relationship in
mutant cells is most easily explained as a consequence of their
lower input resistance, while more rapid intraburst spiking is likely
due tochanges in ionchannels. In addition toalteredspike-related
sodium and potassium channels, it is possible that the rapid
intraburst spiking in Tsc1DE12/DE12 cells is caused by altered den-
sity or kinetics of low-threshold calcium channels. Additionally,
the ectopic production of PV, a protein that acts as a slow Ca2+
buffer, in Tsc1DE12/DE12 thalamic relay neurons may disrupt inter-
nal Ca2+ dynamics, which can affect gene transcription, synaptic
function, andmembranepotential andcouldcontribute tosomeof
the physiological changes we describe (Schwaller, 2010).
Importantly, our data show that the effects of early mutation
spread well beyond the cells with the Tsc1 deletion. Individually
mutated neurons ensnare the neocortex into hyperexcitable net-
works, as evidenced by abnormal LFPs in SI. Thus, disruption of
an anatomically distinct but functionally connected node within
a circuit can propagate the disease phenotype. Comparing the
effects of early and late Tsc1 deletion is informative. We did
not detect abnormal physiological properties of Tsc1DE18/DE18
VB neurons, which indicates that, at least for VB neurons, there
is a critical window of Tsc1/mTOR required to establish proper
intrinsic excitability properties. Nevertheless, a striking finding
is that neocortical (SI) LFP activity was altered in some E18.5
deletion animals. The most likely reason for the global abnormal-
ities is that feedback loops involving multiple thalamic nuclei
have altered physiology, which is propagated both locally and
to other brain regions. The sources of altered feedback may
involve thalamic nuclei that undergo substantial recombination
at E18.5 (such as Po) and that subsequently disrupt the reticulo-
thalamic or the corticothalamic loops. By comparing the early
versus later deletion of Tsc1, we are able to discern that abnor-
malities, even in a small proportion of cells, can cause reverber-
ating global changes in neural activity.
Comparison of our thalamic Tsc1mutant phenotypes to other
mousemodels can be informative in considering the contribution
of individual brain regions to global neural dysfunction. Behavior-
ally, Tsc1DE12/DE12 animals groomed excessively, to the extent
that they gave themselves severe lesions. A similar overgrooming
phenotype has been described in genetic mouse models of
autism and obsessive compulsive disorder in which Slitrk5,
Shank3, or Sapap3 is deleted (Welch et al., 2007; Shmelkov
et al., 2010; Pec¸a et al., 2011). Because striatum-specific gene
rescue can ameliorate the phenotype, these groups implicate
the corticostriatal circuit in causing abnormal repetitive behav-
iors. The thalamus projects both directly and indirectly, viaNeuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc. 905
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abnormal thalamicmodulation of the striatum in ourmice contrib-
utes to the repetitive grooming phenotype. However, it is
possible that sparse recombination in other subcortical brain
structures, such as the striatum and hindbrain, may also
contribute to the behavioral changes. Tsc1 or Tsc2 knockout in
Purkinje cells of the cerebellum also causes repetitive grooming
(Tsai et al., 2012; Reith et al., 2013), possibly by disrupting signals
from the cerebellum to themotor cortex, which are relayed by the
ventrolateral thalamus. In addition, all Tsc1DE12/DE12 and some
Tsc1DE18/DE18mice experience seizures and abnormal neural ac-
tivity with epileptiform features. Seizures are a common feature
of TS clinically. Tsc1 knockout in forebrain neurons leads to sei-
zures in 10% of mice (Meikle et al., 2007), while Tsc1 deletion in
astrocytes (and likely neurons as well; Casper and McCarthy,
2006) causes frequent seizures and premature death (Uhlmann
et al., 2002). Widespread deletion of Tsc1 in neural progenitors
has also been shown to cause spontaneous seizures in adult
mice (Goto et al., 2011). Ours, however, is a conditional Tsc1
knockout that causes both seizures and overgrooming. Although
one may presume that this is simply because the thalamus is a
central structure and its dysregulation therefore compromises
multiple functional circuits, the explanation cannot be that sim-
ple; in the Meikle et al. and Goto et al. studies, Tsc1 recombina-
tion occurs in the thalamus aswell as the rest of the forebrain. The
fact that more comprehensive Tsc1 knockouts do not produce
similar overgrooming suggests that perturbing a single node of
a neural network has the potential to be more deleterious than
disrupting the entire network, perhaps because global homeo-
static mechanisms are not invoked when only part of a highly in-
terconnected and integrative system is dysregulated. This is an
important consideration for brain structures, such as the thal-
amus, which feature complex feedback loops and widespread
reciprocal connectivity that could amplify and spread the effects
of a slight functional imbalance. This concept is particularly rele-
vant given themosaic nature of TS in humans, inwhich subsets of
cells undergo biallelic TSC1/2mutations, leading to discrete co-
horts of mutant cells (Crino et al., 2010). It is important to note,
however, that while thalamic Tsc1 knockout replicates salient
features of TS,we are not implying that TS is a disease of the thal-
amus. Rather, our findings suggest that the thalamus and other
subcortical regions warrant further investigation and that the
complex nature of disorders like TS involvemultiple brain regions
that may respond differentially to the same genetic insult.
The phenotypes related to E12.5 versus E18.5 Tsc1 inactiva-
tion suggest three contributing factors: the spatial pattern of
recombination, the overall number of affected cells, and the
developmental timing of Tsc1 inactivation. The spatial pattern
of recombination is clearly important and experimentally arises
from the dynamic expression of the Gbx2 gene regulatory ele-
ments that drive CreER expression (Chen et al., 2009). The
dynamic recombination pattern causes the MD, MG, and AM
nuclei to undergo recombination at both E12.5 and E18.5. In
contrast, the Pf and VB nuclei are largely spared by recombina-
tion at E18.5. This differential involvement of nuclei probably
leads to distinct consequences. The Pf and VB nuclei project,
either directly or indirectly, to the dorsolateral striatum (Pan
et al., 2010), which is a central component in a circuit that regu-906 Neuron 78, 895–909, June 5, 2013 ª2013 Elsevier Inc.lates a syntactic chain of grooming behaviors (Cromwell and
Berridge, 1996). Disruption of this circuit at E12.5, but not at
E18.5, could underlie the compulsive grooming behavior in
Tsc1DE12/DE12, but not Tsc1DE18/DE18, mutant animals. Alterna-
tively, there may be a threshold extent of mosaicism that can
be tolerated and compensated for by the brain, above
which compensatory mechanisms become ineffective. In this
regard, the lower overall number of recombined cells in the
Tsc1DE18/DE18 thalamus might place the system near the toler-
ance threshold, resulting in abnormal neural activity but with
only a subset of animals experiencing overt seizures and only
upon external stimulation. In contrast, the extensive recombina-
tion within the Tsc1DE12/DE12 thalamus may be above the toler-
ance threshold, resulting in unmitigated disruption of thalamic
development and function. Finally, because mTOR regulates
many developmental cellular programs including proliferation,
cell growth, axon formation, and synapse formation and mainte-
nance, it is also possible that the later deletion of Tsc1 results in a
diminished phenotype simply because there is a critical period
during which thalamic neurons require functional Tsc1. By
E18.5, thalamic neurons have already extended their axons to
their cortical target regions, so this developmental event would
be spared when Tsc1 inactivation occurs at E18.5 but may be
affected by earlier Tsc1 inactivation. This idea is consistent
with the fact that, at the single-cell level, recombined VB neurons
display aberrant protein expression and altered electrophysio-
logical properties when recombination occurs at E12.5, while
VB neurons are apparently unaffected when recombination
occurs at E18.5.
It is likely that all three of these factors—the specific cells that
suffer the genetic insult, the number of cells that are affected,
and the developmental stage at which the genetic hit
occurs—contribute to the distinct E12.5 and E18.5 phenotypes
to some degree. Although this complex interplay of multiple
factors precludes making simple conclusions about mecha-
nisms, it does nicely mimic the complex nature of mosaic
disorders such as TS. Mosaic genetic diseases can have
extremely variable penetrance, expressivity, and severity. The
factors that can contribute to this disease variability, similar to
those in our mouse model, include (1) when during develop-
ment the initial genetic mutation occurs, (2) in which cell that
mutation happens (and how the gene functions in that cell
type), and (3) how extensively that initial cell’s lineage contrib-
utes to the final organism (Hall, 1988). Our temporally and
spatially controllable mouse model of TS allows us to manipu-
late where and when the Tsc1 gene is deleted, which is instruc-
tive in understanding the consequences of mosaic genetic in-
sults at distinct stages of development. Future studies that
further parse the contributions of these factors will be instru-
mental for understanding the developmental underpinnings
and mechanisms that contribute to tuberous sclerosis and to
mosaic diseases in general.EXPERIMENTAL PROCEDURES
Mice, Tissue Processing, and Cellular Analysis
Tsc1fl, Rosa26loxP-STOP-loxP-LacZ (R26LacZ), R26loxP-STOP-loxP-tdTomato
(R26tdTomato), and Gbx2CreER-IRES-eGFP (Gbx2CreER) mice were described
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Tsc1 Deletion during Thalamic Developmentpreviously (Soriano, 1999; Kwiatkowski et al., 2002; Chen et al., 2009;Madisen
et al., 2010). Mice were housed and handled in accordance with Brown
University Institutional Animal Care and Use Committee guidelines. Genotyp-
ing, tamoxifen, immunohistochemistry (IHC), antibodies, and cytochrome
oxidase (CO) staining are described in Brown et al. (2009) and Ellisor et al.
(2009) and Supplemental Experimental Procedures. Identical exposure set-
tings were used when comparing labeling intensity across the three geno-
types. For neuron density analysis, a barrel outline was created based on
CO+ staining (‘‘barrel hollow’’) and a perimeter was made 15 mm outside the
inner outline (‘‘barrel wall’’). The area and the number of NeuN-positive objects
in the barrel hollow and wall regions were determined and analyzed for signif-
icance by Student’s t test. For cell size analysis, five thalamic regions from five
medial-to-lateral brain sections were assessed. The measure function (Voloc-
ity) was used to calculate the perimeter and area of all outlined cell bodies.
Generalized estimating equations (log-normal generalized model) were used
to compare genotypes with regards to neuronal size. Pairwise comparisons
weremade using orthogonal contrast statements, with p values adjusted using
the Holm test to maintain family-wise alpha at 0.05. Statistical and experi-
mental details are provided in the Supplemental Experimental Procedures.
Whole-Cell Recordings
Brain slice preparation, solutions, and recording conditions (Agmon and
Connors, 1991; Cruikshank et al., 2010, 2012) are provided in detail in the
Supplemental Experimental Procedures. Data were collected with Clampex
10.0 and analyses were performed post hoc using Clampfit 10.0. Resting
membrane potentials (Rm), input resistances (Rin), membrane time constants
(tm), and input capacitances (Cin) were determined as described in the
Supplemental Experimental Procedures. Burst properties were characterized
by holding the soma at a membrane potential of 60 mV with intracellular
current and subsequently injecting large negative currents. Tonic and single
action potential properties were characterized by holding the soma at a mem-
brane potential of 50 mV with intracellular current and injecting suprathresh-
hold positive current. Single action potential data were obtained by injecting
the minimum current needed to elicit an action potential. Afterhyperpolariza-
tions were evoked by injecting a 2 ms suprathreshold positive current. Gener-
alized hierarchical linear modeling was used to test for differential effects of
gene deletion. Comparisons by genotype were made using orthogonal linear
comparisons.
LFP Recordings
Surgical procedures, recordings, and analysis are described in the Supple-
mental Experimental Procedures. NeuroNexus probes were used for
recording sessions. LFP signals were sampled, filtered, and recorded using
a Cheetah Data Acquisition System (NeuraLynx). The probe was lowered
1,600 mm and responses to vibrissa deflections confirmed electrode place-
ment in SI. Ten minutes of pre- and postbaseline activity and a stimulus
period were recorded. Stimuli periods had a mean period of 5 s. For each an-
imal, a single SI recording session was selected for LFP analysis using the
layer IV contact. Recorded signals were low-pass filtered, downsampled,
and clipping artifacts were removed. Data were analyzed using MATLAB.
The power spectral density (PSD) for 20 s nonoverlapping time windows
was estimated using Welch’s method with a 4,096 point FFT, normalized
by dividing by the sum of the PSD across all frequencies and smoothed using
a 5 pt moving average filter. Relative power at 3 Hz was calculated as the ratio
of the normalized PSD at 3 Hz by the value at 1 Hz for each time window,
averaged across the session. The number of 20 s epochs that exceeded
97.5th percentile of normalized 3 Hz power was counted. Two-tailed two-
sample t tests were performed by grouping all controls versus all mutants
(significance level, a of 0.05).
Behavioral Analysis
An independent observer assessed videos to score seizures and overgroom-
ing as detailed in the Supplemental Experimental Procedures. Generalized
estimating equations were used to compare genotypes with regards to
percent minutes grooming (binomial generalized model grooming/total
minutes) and seizure frequency (negative-binomial generalized model offset
by log total hours). Pairwise comparisons were made using orthogonalcontrast statements, with p values adjusted using the Holm test to maintain
family-wise alpha at 0.05. Sensorimotor testing details are described in the
Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, Supplemental
Experimental Procedures, and two movies and can be found with this article
online at http://dx.doi.org/10.1016/j.neuron.2013.03.030.ACKNOWLEDGMENTS
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